Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.

Although there was no significant difference in the DFS between the NLR groups according to the multivariate analysis, the difference may be significant with a longer follow-up time and a larger patient population.

also in 13,097 other papers